All Cosmos Bio-Tech Holding Corporation (4148.TW)
TWD 45.55
(-1.83%)
TWD 45.55
(-1.83%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 189.89 Million TWD | -70.58% |
| 2022 | 645.49 Million TWD | 143.02% |
| 2021 | 265.61 Million TWD | 81.33% |
| 2020 | 146.48 Million TWD | -8.69% |
| 2019 | 160.42 Million TWD | -63.85% |
| 2018 | 443.72 Million TWD | 5.54% |
| 2017 | 420.45 Million TWD | 18.48% |
| 2016 | 354.86 Million TWD | 24.99% |
| 2015 | 283.91 Million TWD | 60.6% |
| 2014 | 176.78 Million TWD | 26.62% |
| 2013 | 139.61 Million TWD | -35.7% |
| 2012 | 217.13 Million TWD | -19.84% |
| 2011 | 270.86 Million TWD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 5.28 Million TWD | -60.68% |
| 2024 Q1 | 23.76 Million TWD | -39.24% |
| 2023 Q3 | 122.42 Million TWD | 252.23% |
| 2023 Q2 | 34.75 Million TWD | -57.7% |
| 2023 Q1 | 82.16 Million TWD | -9.07% |
| 2023 FY | 189.89 Million TWD | -70.58% |
| 2023 Q4 | 39.11 Million TWD | -68.05% |
| 2022 Q1 | 126.89 Million TWD | 13.14% |
| 2022 FY | 645.49 Million TWD | 143.02% |
| 2022 Q4 | 90.36 Million TWD | -67.47% |
| 2022 Q2 | 150.46 Million TWD | 18.57% |
| 2022 Q3 | 277.77 Million TWD | 84.61% |
| 2021 Q3 | 69.94 Million TWD | 6.19% |
| 2021 Q4 | 112.16 Million TWD | 60.36% |
| 2021 FY | 265.61 Million TWD | 81.33% |
| 2021 Q2 | 65.86 Million TWD | 273.41% |
| 2021 Q1 | 17.64 Million TWD | -58.78% |
| 2020 Q3 | 45.58 Million TWD | -41.05% |
| 2020 Q4 | 42.79 Million TWD | -6.12% |
| 2020 Q1 | -19.23 Million TWD | -183.67% |
| 2020 FY | 146.48 Million TWD | -8.69% |
| 2020 Q2 | 77.33 Million TWD | 502.07% |
| 2019 Q3 | 46.43 Million TWD | -48.51% |
| 2019 Q4 | 22.98 Million TWD | -50.5% |
| 2019 FY | 160.42 Million TWD | -63.85% |
| 2019 Q1 | 815 Thousand TWD | -98.44% |
| 2019 Q2 | 90.18 Million TWD | 10966.01% |
| 2018 Q2 | 161.01 Million TWD | 71.8% |
| 2018 FY | 443.72 Million TWD | 5.54% |
| 2018 Q4 | 52.27 Million TWD | -61.76% |
| 2018 Q3 | 136.71 Million TWD | -15.09% |
| 2018 Q1 | 93.72 Million TWD | 25.48% |
| 2017 Q3 | 125.36 Million TWD | 5.66% |
| 2017 Q2 | 118.64 Million TWD | 16.6% |
| 2017 Q1 | 101.75 Million TWD | 21.66% |
| 2017 FY | 420.45 Million TWD | 18.48% |
| 2017 Q4 | 74.69 Million TWD | -40.42% |
| 2016 Q2 | 90.33 Million TWD | 33.31% |
| 2016 Q3 | 104.21 Million TWD | 15.37% |
| 2016 Q4 | 83.63 Million TWD | -19.75% |
| 2016 Q1 | 67.76 Million TWD | -25.32% |
| 2016 FY | 354.86 Million TWD | 24.99% |
| 2015 FY | 283.91 Million TWD | 60.6% |
| 2015 Q2 | 93.71 Million TWD | 721.93% |
| 2015 Q4 | 90.72 Million TWD | 37.82% |
| 2015 Q3 | 65.83 Million TWD | -29.75% |
| 2015 Q1 | 11.4 Million TWD | 0.0% |
| 2014 FY | 176.78 Million TWD | 26.62% |
| 2013 FY | 139.61 Million TWD | -35.7% |
| 2013 Q1 | 42.57 Million TWD | -41.95% |
| 2012 FY | 217.13 Million TWD | -19.84% |
| 2012 Q4 | 73.34 Million TWD | 0.0% |
| 2011 FY | 270.86 Million TWD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Sinon Corporation | 1.42 Billion TWD | 86.644% |
| Taiwan Fertilizer Co., Ltd. | 2.75 Billion TWD | 93.114% |
| CH Biotech R&D Co., Ltd. | 594.67 Million TWD | 68.067% |